HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (45) Citing Articles via Google Scholar Google Scholar Articles by Labbé, R. F. Articles by Stevenson, D. K. Search for Related Content PubMed PubMed Citation Articles by Labbé, R. F. Articles by Stevenson, D. K. Related Collections Pediatric Clinical Chemistry Nutrition Drug Monitoring and Toxicology Endocrinology and Metabolism

Zinc Protoporphyrin: A Metabolite with a Mission

¹ Department of Laboratory Medicine, Box 359743, University of Washington, Seattle, WA 98104.

² Department of Pediatrics, Room S-214, Stanford University, Stanford, CA 94305-5119.
^a Author for correspondence. Fax 206-731-3930; e-mail boblabbe{at}ix netcom.com.

Zinc protoporphyrin (ZnPP) is a normal metabolite that is formed in trace amounts during heme biosynthesis. The final reaction in the biosynthetic pathway of heme is the chelation of iron with protoporphyrin. During periods of iron insufficiency or impaired iron utilization, zinc becomes an alternative metal substrate for ferrochelatase, leading to increased ZnPP formation. Evidence suggests that this metal substitution is one of the first biochemical responses to iron depletion, causing increased ZnPP to appear in circulating erythrocytes. Because this zinc-for-iron substitution occurs predominantly within the bone marrow, the ZnPP/heme ratio in erythrocytes reflects iron status in the bone marrow. In addition, ZnPP may regulate heme catabolism through competitive inhibition of heme oxygenase, the rate-limiting enzyme in the heme degradation pathway that produces bilirubin and carbon monoxide. Physiological roles, especially relating to carbon monoxide and possibly nitric oxide production, have been suggested for ZnPP. Clinically, ZnPP quantification is valuable as a sensitive and specific tool for evaluating iron nutrition and metabolism. Diagnostic determinations are applicable in a variety of clinical settings, including pediatrics, obstetrics, and blood banking. ZnPP analytical methodologies for clinical studies are discussed. In addition to diagnostic tests and metabolic studies, ZnPP has a potential therapeutic application in controlling bilirubin formation in neonates as a preventive measure for hyperbilirubinemia. Biochemical research techniques, both in vivo and in vitro, are described for further studies into the role of ZnPP in metabolism and physiology.

The following articles in journals at HighWire Press have cited this article:

				K. El Fadili, M. Imbeault, N. Messier, G. Roy, B. Gourbal, M. Bergeron, M. J. Tremblay, D. Legare, and M. Ouellette Modulation of Gene Expression in Human Macrophages Treated with the Anti-Leishmania Pentavalent Antimonial Drug Sodium Stibogluconate Antimicrob. Agents Chemother., February 1, 2008; 52(2): 526 - 533. [Abstract] [Full Text] [PDF]

				A. L. Lagan, D. D. Melley, T. W. Evans, and G. J. Quinlan Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L161 - L174. [Abstract] [Full Text] [PDF]

				C. Pondarre, D. R. Campagna, B. Antiochos, L. Sikorski, H. Mulhern, and M. D. Fleming Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis Blood, April 15, 2007; 109(8): 3567 - 3569. [Abstract] [Full Text] [PDF]

				M. B. Zimmermann, S. Muthayya, D. Moretti, A. Kurpad, and R. F. Hurrell Iron fortification reduces blood lead levels in children in Bangalore, India. Pediatrics, June 1, 2006; 117(6): 2014 - 2021. [Abstract] [Full Text] [PDF]

				R. S. Ohgami, D. R. Campagna, B. Antiochos, E. B. Wood, J. J. Sharp, J. E. Barker, and M. D. Fleming nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse Blood, November 15, 2005; 106(10): 3625 - 3631. [Abstract] [Full Text] [PDF]

				S. B. Blumenthal, A. K. Kiemer, G. Tiegs, S. Seyfried, M. Holtje, B. Brandt, H.-D. Holtje, S. Zahler, and A. M. Vollmar Metalloporphyrins inactivate caspase-3 and -8 FASEB J, August 1, 2005; 19(10): 1272 - 1279. [Abstract] [Full Text] [PDF]

				M. B Zimmermann, L. Molinari, F. Staubli-Asobayire, S. Y Hess, N. Chaouki, P. Adou, and R. F Hurrell Serum transferrin receptor and zinc protoporphyrin as indicators of iron status in African children Am. J. Clinical Nutrition, March 1, 2005; 81(3): 615 - 623. [Abstract] [Full Text] [PDF]

				W. E. Crowe, L. M. Maglova, P. Ponka, and J. M. Russell Human cytomegalovirus-induced host cell enlargement is iron dependent Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1023 - C1030. [Abstract] [Full Text] [PDF]

				T. M. Kemmer, M. E. Bovill, W. Kongsomboon, S. J. Hansch, K. L. Geisler, C. Cheney, B. K. Shell-Duncan, and A. Drewnowski Iron Deficiency Is Unacceptably High in Refugee Children from Burma J. Nutr., December 1, 2003; 133(12): 4143 - 4149. [Abstract] [Full Text] [PDF]

				Z. Mei, I. Parvanta, M. E Cogswell, E. W Gunter, and L. M Grummer-Strawn Erythrocyte protoporphyrin or hemoglobin: which is a better screening test for iron deficiency in children and women? Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1229 - 1233. [Abstract] [Full Text] [PDF]

				E. Beutler, A. V. Hoffbrand, and J. D. Cook Iron Deficiency and Overload Hematology, January 1, 2003; 2003(1): 40 - 61. [Abstract] [Full Text] [PDF]